Viatris (Biosimilar Business) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Viatris (Biosimilar Business) General Information

Description

Operator of biologics business unit intended to treat various types of health conditions. The company offers therapeutic alternatives for diabetes, autoimmune disorders and multiple cancers, thereby helping patients by increasing access to healthcare technologies and supporting the sustainability of healthcare systems.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • Canonsburg, PA
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • Canonsburg, PA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Viatris (Biosimilar Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Viatris (Biosimilar Business)‘s full profile, request access.

Request a free trial

Viatris (Biosimilar Business) Patents

Viatris (Biosimilar Business) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026163248-A1 Recombinant human hyaluronidase polypeptide variants, method of preparation and pharmaceutical compositions thereof Pending 31-Jan-2025
AU-2022354299-A1 A process of flocculation to purify crude fermentation broth Pending 01-Oct-2021
CA-3231267-A1 A process of flocculation to purify crude fermentation broth Pending 01-Oct-2021
EP-4402154-A1 A process of flocculation to purify crude fermentation broth Pending 01-Oct-2021
EP-4402154-A4 A process of flocculation to purify crude fermentation broth Pending 01-Oct-2021 C07K1/18
To view Viatris (Biosimilar Business)’s complete patent history, request access »

Viatris (Biosimilar Business) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Viatris (Biosimilar Business)‘s full profile, request access.

Request a free trial

Viatris (Biosimilar Business) FAQs

  • Where is Viatris (Biosimilar Business) headquartered?

    Viatris (Biosimilar Business) is headquartered in Canonsburg, PA.

  • What industry is Viatris (Biosimilar Business) in?

    Viatris (Biosimilar Business)’s primary industry is Drug Discovery.

  • Is Viatris (Biosimilar Business) a private or public company?

    Viatris (Biosimilar Business) is a Private company.

  • What is the current valuation of Viatris (Biosimilar Business)?

    The current valuation of Viatris (Biosimilar Business) is .

  • What is Viatris (Biosimilar Business)’s current revenue?

    The current revenue for Viatris (Biosimilar Business) is .

  • Who are Viatris (Biosimilar Business)’s investors?

    Viatris has invested in Viatris (Biosimilar Business).

  • When was Viatris (Biosimilar Business) acquired?

    Viatris (Biosimilar Business) was acquired on 29-Nov-2022.

  • Who acquired Viatris (Biosimilar Business)?

    Viatris (Biosimilar Business) was acquired by Biocon Biologics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process